News

  • Mare Geneticum: Balancing Governance of Marine Genetic Resources In International Waters

    Mare Geneticum: Balancing Governance of Marine Genetic Resources In International Waters

    27.03.2017 - A fair and effective regime regulating benefit-sharing of marine genetic resources (MGR) in areas beyond national jurisdiction (ABNJ) must consider inclusivity of developing states, as well as support scientific research and safeguard investments of the private sector. More

  • New PharmaSea Movie - Exploring the Hidden Potential of the Oceans

    New PharmaSea Movie - Exploring the Hidden Potential of the Oceans

    21.03.2017 - The Arctic is freezing cold and seemingly empty of life. But the coldest, hottest, deepest, and most inaccessible places on Earth are treasure troves for the discovery of novel drug compounds. Watch this video to follow the PharmaSea team to some of these most remote places. Learn about the challenges they face, trips to the seabed, their work in the lab and their findings. More

  • Surveillance Report: „Antimicrobial resistance surveillance in Europe"

    Surveillance Report: „Antimicrobial resistance surveillance in Europe"

    31.01.2017 - Antimicrobial resistance is defined as the “ability of a microorganism to resist the action of one or more antimicrobial agents” (ECDC 2017). The Surveillance Reports highlights that resistance percentages with regard to gram-negative bacteria are increasing. More

  • Video on biodiversity, bioinformatics and biotechnology

    Video on biodiversity, bioinformatics and biotechnology

    14.11.2016 - A documentary film on the hidden biological treasures of the ocean by MicroB3. More

  • UN agrees to fight 'the biggest threat to modern medicine': antibiotic resistance

    UN agrees to fight 'the biggest threat to modern medicine': antibiotic resistance

    21.09.2016 - All 193 United Nations member states are set to sign a declaration agreeing to combat “the biggest threat to modern medicine” in Wednesday’s high-level meeting on antibiotic resistance. More

  • Medicine from the oceans

    Medicine from the oceans

    11.07.2016 - The sea is full of microorganisms, microscopically small creatures such as bacteria, algae or fungi. Despite these potentials and the fact that the deep sea is one of the largest ecosystems in the world, only a small part of the marine biodiversity has been discovered. Projects such as MaCuMBA or PharmaSea strive to improve this state of knowledge. More

  • Science Year 2016/2017 in Germany – Seas and Oceans

    Science Year 2016/2017 in Germany – Seas and Oceans

    31.05.2016 - What do we know about our seas and oceans? Definitively not enough! Find out about the Science Year 2016/2017 in Germany and My Ocean Sampling Day 2016. More

  • First discovery in United States of colistin resistance in a human E. coli infection

    First discovery in United States of colistin resistance in a human E. coli infection

    27.05.2016 - The Multidrug Resistant Organism Repository and Surveillance Network at the Walter Reed Army Institute of Research characterized a transferrable gene for colistin resistance in the United States that may herald the emergence of truly pan-drug resistant bacteria. More

  • How to conserve and sustainably manage biodiversity in the high seas?

    How to conserve and sustainably manage biodiversity in the high seas?

    24.04.2016 - Marine Areas Beyond National Jurisdiction (ABNJ) are commonly referred to as the high seas. The high seas are biodiversity-rich and complex ecosystems that make up 40 % of the surface of the planet and are not controlled by one single nation. Often they are regarded as the world’s last global common. More

  • US tasks Basilea with antibiotics launch

    US tasks Basilea with antibiotics launch

    20.04.2016 - The US government is forking out up to US$100m to get Basilea Pharmaceutica’s broad-spectrum antibiotic ceftobiprole on the US market. In the EU, ceftobiprole is already available. More

  • What’s new with the Nagoya Protocol?

    What’s new with the Nagoya Protocol?

    24.03.2016 - One of the overarching goals of the Convention on Biological Diversity (CBD) is the fair distribution of advantages that arise from the utilisation of genetic resources. More

  • Pharma demands: fight superbugs now

    Pharma demands: fight superbugs now

    18.01.2016 - Stop squandering antibiotics and make research profitable again: at the World Economic Forum in Swiss Davos, 83 pharmaceutical companies have called for a unified approach towards the threat of antimicrobial resistance. More

  • PharmaSea congratulates Nobel Prize winners

    PharmaSea congratulates Nobel Prize winners

    18.10.2015 - PharmaSea, a project that focuses development of new substances from marine organisms, congratulates three scientists, who were awarded the 2015 Nobel Prize on Medicine this year for the discovery of novel natural products that became impactful therapies for infections by roundworm parasites and malaria. More

  • PharmaSea researcher Marla Trindade wins science award

    PharmaSea researcher Marla Trindade wins science award

    27.08.2015 - Prof. Marla Trindade has won the DST Distinguished Young Woman Researcher Award for her multidisciplinary work, aiming to develop biotechnologies from bacteria and their associated viruses, to benefit industries in the health. More

  • Tapping the Source of Marine Biotechnological Potential: PharmaSea, MaCuMBA, Micro B3

    Tapping the Source of Marine Biotechnological Potential: PharmaSea, MaCuMBA, Micro B3

    18.06.2015 - The three EU-funded projects PharmaSea, MaCuMBA and Micro B3 have collaborated to produce a new marine microbes research update that explores the cross-over between the projects’ respective objectives as they seek to exploit the virtually untapped resource of marine microorganisms, which account for 98% of ocean biomass. More

  • Royal Society of Edinburgh honour for PharmaSea's project leader Marcel Jaspars

    Royal Society of Edinburgh honour for PharmaSea's project leader Marcel Jaspars

    11.03.2015 - Professor Marcel Jaspars, PharmaSea's project leader and chair in Chemistry and director of the Marine Biodiscovery Centre at the University of Aberdeen, has joined Scotland’s prestigious educational charity, The Royal Society of Edinburgh (RSE). Jaspars is recognised for his work on the discovery of new pharmaceuticals and enzymes from marine biodiversity. More

  • PharmaSea wins Communication Award

    PharmaSea wins Communication Award

    07.12.2014 - PharmaSea has won the CommNet Impact Award 2014 in the category "Engaging citizens" and was praised for the high volume of media attention it had generated. With this award CommNet is rewarding projects working across the bioeconomy, that have demonstrated excellence in communicating to European citizens, policy-makers, industry or young people. The winning projects in the other categories were: Food4Me, BioConSepT and I.Family. The awards ceremony took place at the CommNet’s 3rd Bioeconomy Forum & Final Conference at the Crowne Plaza Hotel in Brussels, Belgium on December 3. More

  • PharmaSea at the UN Headquarters

    PharmaSea at the UN Headquarters

    03.08.2014 - PharmaSea recently participated in a side event at a meeting of the "United Nations Ad Hoc Open-ended Informal Working Group" to study issues relating to the conservation and sustainable use of marine biological diversity beyond areas of national jurisdiction. The meeting took place in New York at the UN Headquarters from the 16th to 20th June 2014. The side event – organised by PharmaSea WP6 partners; IUCN-ELC, eCOAST and University of Aberdeen, in collaboration with MarBank and MicroB3 partner EMBL-EBI – was entitled, Research and Development on Marine Genetic Resources – Current Practices within the Marine Scientific Community. More

  • WHO: Antibiotic resistance is a worldwide threat to public health

    WHO: Antibiotic resistance is a worldwide threat to public health

    02.05.2014 - A new WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries. The report is the first to look at antimicrobial resistance, including antibiotic resistance, globally and reveals that this serious threat is no longer a prediction for the future. It is happening right now in every region of the world and has the potential to affect anyone, of any age, in any country. “Without urgent, coordinated action by many stakeholders, the world is headed for a post-antibiotic era, in which common infections and minor injuries which have been treatable for decades can once again kill,” says Dr Keiji Fukuda, WHO’s Assistant Director-General for Health Security. More

  • €9m EU-project on deep-sea organisms started

    €9m EU-project on deep-sea organisms started

    13.02.2013 - The collaborative project PharmaSea will bring European researchers to some of the deepest, coldest and hottest places on the planet. Scientists from the UK, Belgium, Norway, Spain, Ireland, Germany, Italy and Denmark will work together to collect and screen samples of mud and sediment from huge, previously untapped, oceanic trenches. The large-scale, four-year project is backed by more than €9.5 million of EU funding and brings together 24 partners from 13 countries from industry, academia and non-profit organisations. The international team of scientists is led by Professor Marcel Jaspars of the University of Aberdeen in Scotland, and coordinated by Dr. Camila Esguerra of the University of Leuven in Belgium. More